Noticias de RNA_US

Noticias del mercado

Últimas noticias sobre RNA_US — 53 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: RNA_US ✕ 53 resultados
26/02/2026 RNA_US — Stock Titan
One-year Duchenne study ties treatment to near-normal creatine kinase levels
26/02/2026 RNA_US — Stock Titan
Avidity Biosciences (RNA) investors approve Novartis merger and Atrium spin-off
25/02/2026 RNA_US — MarketScreener
Avidity Biosciences, Inc.(NasdaqGM: RNAM) dropped from NASDAQ Biotechnology Index
23/02/2026 RNA_US — DirectorsTalk Interviews
Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring Growth Potential Amidst 434% Revenue Surge
23/02/2026 RNA_US — Quantisnow
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
23/02/2026 RNA_US — Stock Titan
Avidity Biosciences (RNA) resets special meeting, eyes late-Feb merger
23/02/2026 RNA_US — PR Newswire
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
23/02/2026 RNA_US — TradingView
Avidity Biosciences, Inc. SEC 10-K Report
23/02/2026 RNA_US — TipRanks
Avidity Biosciences Advances Toward Novartis Merger Completion
23/02/2026 RNA_US — Investing.com
Avidity postpones stockholder meeting, sets merger dates
18/02/2026 RNA_US — PR Newswire
The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
18/02/2026 RNA_US — Stock Titan
Early trial of Avidity therapy eases key symptoms in inherited muscle disease
18/02/2026 RNA_US — Investing.com
Avidity’s myotonic dystrophy drug shows promising results in trial

Página 3 de 3

keyboard_arrow_up